254 related articles for article (PubMed ID: 23377520)
1. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
Schmieder GJ; Huang EY; Jarratt M
J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
Piacquadio DJ; Chen DM; Farber HF; Fowler JF; Glazer SD; Goodman JJ; Hruza LL; Jeffes EW; Ling MR; Phillips TJ; Rallis TM; Scher RK; Taylor CR; Weinstein GD
Arch Dermatol; 2004 Jan; 140(1):41-6. PubMed ID: 14732659
[TBL] [Abstract][Full Text] [Related]
3. Short incubation PDT versus 5-FU in treating actinic keratoses.
Smith S; Piacquadio D; Morhenn V; Atkin D; Fitzpatrick R
J Drugs Dermatol; 2003 Dec; 2(6):629-35. PubMed ID: 14711141
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light.
Jeffes EW; McCullough JL; Weinstein GD; Kaplan R; Glazer SD; Taylor JR
J Am Acad Dermatol; 2001 Jul; 45(1):96-104. PubMed ID: 11423841
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study.
Jeffes EW; McCullough JL; Weinstein GD; Fergin PE; Nelson JS; Shull TF; Simpson KR; Bukaty LM; Hoffman WL; Fong NL
Arch Dermatol; 1997 Jun; 133(6):727-32. PubMed ID: 9197826
[TBL] [Abstract][Full Text] [Related]
6. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage.
Touma D; Yaar M; Whitehead S; Konnikov N; Gilchrest BA
Arch Dermatol; 2004 Jan; 140(1):33-40. PubMed ID: 14732657
[TBL] [Abstract][Full Text] [Related]
7. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses.
Lang K; Schulte KW; Ruzicka T; Fritsch C
Skin Therapy Lett; 2001 Sep; 6(10):1-2, 5. PubMed ID: 11685275
[TBL] [Abstract][Full Text] [Related]
8. Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond.
Bissonette R; Bergeron A; Liu Y
J Drugs Dermatol; 2004; 3(1 Suppl):S26-31. PubMed ID: 14964758
[TBL] [Abstract][Full Text] [Related]
9. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
10. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
[TBL] [Abstract][Full Text] [Related]
11. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
12. Aminolevulinic acid hydrochloride with photodynamic therapy: efficacy outcomes and recurrence 4 years after treatment.
Fowler JF; Zax RH
Cutis; 2002 Jun; 69(6 Suppl):2-7. PubMed ID: 12095067
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study.
Szeimies RM; Karrer S; Sauerwald A; Landthaler M
Dermatology; 1996; 192(3):246-51. PubMed ID: 8726640
[TBL] [Abstract][Full Text] [Related]
14. Topical aminolevulinic acid HCl photodynamic therapy.
Ormrod D; Jarvis B
Am J Clin Dermatol; 2000; 1(2):133-9; discussion 140-1. PubMed ID: 11702313
[TBL] [Abstract][Full Text] [Related]
15. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
Dragieva G; Hafner J; Dummer R; Schmid-Grendelmeier P; Roos M; Prinz BM; Burg G; Binswanger U; Kempf W
Transplantation; 2004 Jan; 77(1):115-21. PubMed ID: 14724445
[TBL] [Abstract][Full Text] [Related]
16. Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study.
Saenz-Guirado S; Ayen-Rodriguez A; Galvez-Moreno M; Velasco-Amador JP; Llamas-Molina JM; Ruiz-Villaverde R; Molina-Leyva A
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104031. PubMed ID: 38438001
[TBL] [Abstract][Full Text] [Related]
17. The impact of occlusive vs non-occlusive application of methyl aminolevulinate on the efficacy and tolerability of daylight photodynamic therapy for actinic keratosis.
Trave I; Salvi I; Serazzi FA; Schiavetti I; Luca L; Parodi A; Cozzani E
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104049. PubMed ID: 38490345
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic and fluorescence evaluation of 20% 5-aminolevulinic acid-mediated photodynamic therapy in actinic keratosis.
Li L; Li Y; Dong H; Yan J; Zhang Y; Zhang C; Xu X
Photodiagnosis Photodyn Ther; 2024 Jun; 47():104100. PubMed ID: 38663488
[TBL] [Abstract][Full Text] [Related]
19. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light.
Fink-Puches R; Hofer A; Smolle J; Kerl H; Wolf P
J Photochem Photobiol B; 1997 Nov; 41(1-2):145-51. PubMed ID: 9440322
[TBL] [Abstract][Full Text] [Related]
20. The evolving role of aminolevulinic acid hydrochloride with photodynamic therapy in photoaging.
Gold MH
Cutis; 2002 Jun; 69(6 Suppl):8-13. PubMed ID: 12095068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
